<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02925637</url>
  </required_header>
  <id_info>
    <org_study_id>adamit_t</org_study_id>
    <nct_id>NCT02925637</nct_id>
  </id_info>
  <brief_title>Effectiveness of FACoT for Individuals Post Stroke</brief_title>
  <official_title>Effectiveness of a Novel Meta-cognitive-functional Intervention (FACoT) for Individuals Post Mild-moderate Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bait Balev Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel Aviv University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bait Balev Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To develop and assess the effectiveness of a novel cognitive-functional intervention (FACoT)&#xD;
      in occupational therapy for people after mild to moderate stroke.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 12, 2017</start_date>
  <completion_date type="Actual">February 27, 2020</completion_date>
  <primary_completion_date type="Actual">February 27, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in scores of The Canadian Occupational Performance Measure (COPM)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention -10-13 weeks later) and time 2 (follow-up- three month later)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in scores of the Instrumental Activities of Daily Living (IADL) scale</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores of Reintegration to Normal Living Index (RNL)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores of Short Form-12v2 Health Survey (SF-12v2)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in scoe of New general self efficacy scale (NGSE)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores of Patient competency rating scale (PCRS)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores Self Regulation Skills Interview (SRSI)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores of Montreal Cognitive Assessment (MoCA)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores of Trail making test (TMT)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores of zoo-map</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores of Dysexecutive Questionnaire (DEX)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3month later)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric Depression Scale - short form (GDS-SF)</measure>
    <time_frame>Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>National Institutes of Health Stroke Scale (NIHSS)</measure>
    <time_frame>baseline (week 0)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Functional Independence Measure (FIM)</measure>
    <time_frame>baseline (week 0)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>demographic questionnaire</measure>
    <time_frame>baseline (week 0)</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>FACoT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>treatment group will receive FACoT, that include one to one 10 treatment sessions. the treatment sessions will include: functional activities, cognitive activities and strategies (pencil-pen treatment), and behavioural strategies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control group receiving standard care - cognitive and functional assesment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FaCoT</intervention_name>
    <description>The intervention will include: functional activities, cognitive activities and strategies (pencil-pen treatment), and behavioural strategies</description>
    <arm_group_label>FACoT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        inclusion criteria:&#xD;
&#xD;
          -  &gt;18 years&#xD;
&#xD;
          -  at least three years post stroke&#xD;
&#xD;
          -  severity mild to moderate (NIHSSâ‰¤5)&#xD;
&#xD;
          -  independent prior to the stroke&#xD;
&#xD;
          -  can understand and speak Hebrew&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  with no other neurological or psychiatric conditions&#xD;
&#xD;
          -  without dementia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>tal adamit, PHD student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maccabbi health center ashdod isreal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maccabi</name>
      <address>
        <city>Ashdod</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>August 3, 2016</study_first_submitted>
  <study_first_submitted_qc>October 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2016</study_first_posted>
  <last_update_submitted>April 11, 2021</last_update_submitted>
  <last_update_submitted_qc>April 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

